SRR1499442
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- DNA_REPAIR+0.304
- OXIDATIVE_PHOSPHORYLATION+0.288
- MYC_TARGETS_V2+0.154
- MYC_TARGETS_V1+0.143
- UNFOLDED_PROTEIN_RESPONSE+0.100
- PROTEIN_SECRETION+0.084
- SPERMATOGENESIS+0.049
- KRAS_SIGNALING_DN+0.043
- PEROXISOME+0.016
- PI3K_AKT_MTOR_SIGNALING+0.016
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.597
- TNFA_SIGNALING_VIA_NFKB-0.572
- EPITHELIAL_MESENCHYMAL_TRANSITION-0.567
- ANGIOGENESIS-0.558
- IL6_JAK_STAT3_SIGNALING-0.546
- INTERFERON_GAMMA_RESPONSE-0.526
- INFLAMMATORY_RESPONSE-0.523
- KRAS_SIGNALING_UP-0.482
- TGF_BETA_SIGNALING-0.480
- ALLOGRAFT_REJECTION-0.447
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1441141 | GTEX | — | 0.989 |
| 2 | SRR1340420 | GTEX | — | 0.988 |
| 3 | SRR1441118 | GTEX | — | 0.981 |
| 4 | SRR1393068 | GTEX | — | 0.979 |
| 5 | SRR659412 | GTEX | — | 0.978 |
| 6 | SRR1406917 | GTEX | — | 0.976 |
| 7 | SRR1429891 | GTEX | — | 0.976 |
| 8 | SRR1097392 | GTEX | — | 0.976 |
| 9 | SRR1407560 | GTEX | — | 0.975 |
| 10 | SRR1316874 | GTEX | — | 0.975 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 10 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| DNA_REPAIR | 0.304 | Idelalisib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.288 | Remibrutinib | — uncovered |
| MYC_TARGETS_V2 | 0.154 | Idelalisib | — uncovered |
| MYC_TARGETS_V1 | 0.143 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.100 | Idelalisib | — uncovered |
| PROTEIN_SECRETION | 0.084 | Remibrutinib | — uncovered |
| SPERMATOGENESIS | 0.049 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.043 | Remibrutinib | — uncovered |
| PEROXISOME | 0.016 | Idelalisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.016 | Inavolisib | — uncovered |